Danville, CA, United States of America

Rajesh Shrotriya


Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 162(Granted Patents)


Company Filing History:


Years Active: 2000-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Rajesh Shrotriya

Introduction

Rajesh Shrotriya is a prominent inventor based in Danville, California. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His innovative work is primarily focused on the formulation of drugs that have the potential to improve patient outcomes.

Latest Patents

Among his most notable inventions is a patented formulation of Paclitaxel, a medication used in the treatment of various cancers. This patent reflects his commitment to enhancing drug efficacy while ensuring safety and accessibility for patients in need.

Career Highlights

Rajesh currently works at Supergen, Inc., a company known for its dedication to developing innovative therapeutics. His expertise in pharmaceutical formulations has allowed him to play a crucial role in the company, contributing to advancements that significantly impact healthcare.

Collaborations

Throughout his career, Rajesh has collaborated with notable professionals in the industry, including Joseph Rubinfeld and Ashok Y Gore. These partnerships have fostered an environment of innovation and creativity, leading to the development of groundbreaking formulations and therapies.

Conclusion

Rajesh Shrotriya's work exemplifies the spirit of innovation in the pharmaceutical sector. With five patents to his name, his contributions not only advance scientific understanding but also highlight the essential role of inventors in improving health and wellness through creative solutions. As he continues to collaborate with leading professionals and further his research, his impact on the field of pharmaceuticals is likely to grow even more significant.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…